Open AccessThe Effect of Kelulut Honey on Fasting Blood Glucose and Metabolic Parameters in Patients with Impaired Fasting Glucose
Author(s) -
Mohd Radzniwan A Rashid,
Khairun Nain Nor Aripin,
Fathima Begum Syed Mohideen,
Nizam Baharom,
Khairuddin Omar,
Nik Mohd Shafikudin Md Taujuddin,
Hazira Hanum Mohd Yusof,
Faizul Helmi Addnan
Publication year - 2019
Publication title -
journal of nutrition and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.789
H-Index - 42
eISSN - 2090-0732
pISSN - 2090-0724
DOI - 10.1155/2019/3176018
Subject(s) - impaired fasting glucose , medicine , triglyceride , endocrinology , body mass index , waist , diabetes mellitus , lipid profile , low density lipoprotein , metabolic syndrome , high density lipoprotein , blood pressure , cholesterol , impaired glucose tolerance , type 2 diabetes
Background Impaired fasting glucose (IFG) poses a higher risk of diabetes. Honey has been reported to improve metabolic abnormalities including lowering hyperglycemia. This study is sought at determining the effect of Malaysian Kelulut honey (KH) on fasting glucose levels and metabolic parameters in IFG patients.Methods This quasi-experimental intervention study of 30-day duration was conducted among 60 adult patients with IFG. They were allocated into taking 30 g/day KH group (experimental group, n =30) and not taking KH group (control group, n =30). Body mass index (BMI), waist circumference, blood pressure (BP), fasting glucose, and lipid profile levels (total cholesterol, triglyceride, high-density lipoprotein, and low-density lipoprotein) were measured before and after treatment.Results There was no significant difference in all measured variables at day 30 compared to day 1 within both groups. Similarly, all measured variables neither at day 1 nor at day 30 had shown a statistically significant difference between the groups.Conclusions Daily intake of 30 g KH for 30 days resulted in insignificant effect on fasting glucose, fasting lipid profiles, and other metabolic parameters in patients with IFG. Further studies that employ longer study duration are needed to ascertain the finding.